Galenica Sante AG (GALE) — Capital Reinvestment Ratio
Latest as of December 2025:
0.06x
Galenica Sante AG (GALE) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (CHF190.83 Million) in capital expenditures (CHF12.19 Million). See GALE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
CHF190.83 Million
CHF
Capital Expenditures
CHF12.19 Million
CHF
Data as of
Dec 2025
Most recent filing
Galenica Sante AG Capital Reinvestment Ratio (2014–2025)
This chart tracks Galenica Sante AG's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Galenica Sante AG (2014–2025)
Year-by-year Capital Reinvestment Ratio for Galenica Sante AG from 2014 to 2025. For live market cap and broader valuation context, see Galenica Sante AG stock valuation.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CHF299.76 Million | CHF27.41 Million | ▼ -66.6% |
| 2024 | 0.27x | CHF264.70 Million | CHF72.36 Million | ▼ -19.2% |
| 2023 | 0.34x | CHF225.71 Million | CHF76.37 Million | ▲ +13.9% |
| 2022 | 0.30x | CHF236.87 Million | CHF70.37 Million | ▲ +64.7% |
| 2021 | 0.18x | CHF333.10 Million | CHF60.07 Million | ▼ -27.3% |
| 2020 | 0.25x | CHF224.36 Million | CHF55.69 Million | ▲ +16.0% |
| 2019 | 0.21x | CHF250.44 Million | CHF53.59 Million | ▲ +37.7% |
| 2018 | 0.16x | CHF173.55 Million | CHF26.96 Million | ▼ -20.0% |
| 2017 | 0.19x | CHF144.40 Million | CHF28.05 Million | ▼ -12.8% |
| 2016 | 0.22x | CHF156.82 Million | CHF34.94 Million | ▼ -32.7% |
| 2015 | 0.33x | CHF132.44 Million | CHF43.85 Million | ▼ -32.9% |
| 2014 | 0.49x | CHF84.12 Million | CHF41.54 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow